Verseon’s New Oral Anticoagulant Drug Candidates Demonstrate Lower Bleeding Risk in Vivo

Verseon has developed candidates for a next-generation oral anticoagulant that have the potential to prevent unwanted clots while preserving the body’s ability to stop excessive bleeding